June, 2019 - The House passed a package of four appropriations bills, H.R. 2740, which included the Labor, Health and Human Services, and Education Appropriations bill on June 19, 2019. This package included $41.1 billion for the National Institutes of Health, a $2 billion increase from this year’s funding level. Included in NIH’s funding for FY 2020 is $500 million for the All of Us precision medicine research initiative and $195 million for the Cancer Moonshot research initiative. In addition, H.R. 2740 includes $8.3 billion for the Centers for Disease Control and Prevention ($938 million increase) and $7.6 billion for the Health Resources and Services Administration ($485 million increase).
On June 25th, the House passed another mini-bus of five appropriations bills, H.R. 3055, which provides $3.26 billion in discretionary funding for the Food and Drug Administration. This would be a $184 million increase from this year’s funding level. The total funding for FDA in FY2020, including user fees, would be $5.86 billion. This includes $75 million to accelerate medical product development as authorized in the 21st Century Cures Act.
The U.S. House of Representatives has completed 9 of the 12 appropriations bills for FY 2020. The passed appropriations bills now await action by the Senate before the end of the fiscal year on September 30, 2019.